495 related articles for article (PubMed ID: 26194858)
1. Molecular Testing in Myelodysplastic Syndromes for the Practicing Oncologist: Will the Progress Fulfill the Promise?
Nazha A; Sekeres MA; Gore SD; Zeidan AM
Oncologist; 2015 Sep; 20(9):1069-76. PubMed ID: 26194858
[TBL] [Abstract][Full Text] [Related]
2. The evolving field of prognostication and risk stratification in MDS: Recent developments and future directions.
Lee EJ; Podoltsev N; Gore SD; Zeidan AM
Blood Rev; 2016 Jan; 30(1):1-10. PubMed ID: 26119927
[TBL] [Abstract][Full Text] [Related]
3. Current state of prognostication and risk stratification in myelodysplastic syndromes.
Zeidan AM; Gore SD; Padron E; Komrokji RS
Curr Opin Hematol; 2015 Mar; 22(2):146-54. PubMed ID: 25575032
[TBL] [Abstract][Full Text] [Related]
4. Integrating Genomics in Myelodysplastic Syndrome to Predict Outcomes After Allogeneic Hematopoietic Cell Transplantation.
Nassereddine S; Nishihori T; Padron E; Mahfouz R; Bazarbachi A; Komrokji RS; Kharfan-Dabaja MA
Clin Lymphoma Myeloma Leuk; 2017 Jan; 17(1):7-13. PubMed ID: 27771290
[TBL] [Abstract][Full Text] [Related]
5. Novel therapeutic strategies in myelodysplastic syndromes: do molecular genetics help?
Chung SS
Curr Opin Hematol; 2016 Mar; 23(2):79-87. PubMed ID: 26825694
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetic methods in the diagnosis of myelodysplastic syndromes. A review.
Lukackova R; Gerykova Bujalkova M; Majerova L; Mladosievicova B
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):339-45. PubMed ID: 24263214
[TBL] [Abstract][Full Text] [Related]
7. Implications of molecular genetic diversity in myelodysplastic syndromes.
Bejar R
Curr Opin Hematol; 2017 Mar; 24(2):73-78. PubMed ID: 27875374
[TBL] [Abstract][Full Text] [Related]
8. Molecular Data and the IPSS-R: How Mutational Burden Can Affect Prognostication in MDS.
Nazha A; Bejar R
Curr Hematol Malig Rep; 2017 Oct; 12(5):461-467. PubMed ID: 28844082
[TBL] [Abstract][Full Text] [Related]
9. The molecular basis and clinical significance of genetic mutations identified in myelodysplastic syndromes.
Zhang L; Padron E; Lancet J
Leuk Res; 2015 Jan; 39(1):6-17. PubMed ID: 25465125
[TBL] [Abstract][Full Text] [Related]
10. The need for additional genetic markers for myelodysplastic syndrome stratification: what does the future hold for prognostication?
Otrock ZK; Tiu RV; Maciejewski JP; Sekeres MA
Expert Rev Hematol; 2013 Feb; 6(1):59-68. PubMed ID: 23373781
[TBL] [Abstract][Full Text] [Related]
11. [Molecular Markers of Prognosis in Myelodysplastic Syndromes--Review].
Xu YY; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):285-9. PubMed ID: 26913438
[TBL] [Abstract][Full Text] [Related]
12. The evolving role of genomic testing in assessing prognosis of patients with myelodysplastic syndromes.
Steensma DP
Best Pract Res Clin Haematol; 2017 Dec; 30(4):295-300. PubMed ID: 29156198
[TBL] [Abstract][Full Text] [Related]
13. [Research Advances of Molecular Genetic Abnormality in Myelodysplastic Syndrome--Review].
Pang YB; Wu P; Hua LM; DU X; Wang J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):1248-1252. PubMed ID: 30111440
[TBL] [Abstract][Full Text] [Related]
14. Perspective on how to approach molecular diagnostics in acute myeloid leukemia and myelodysplastic syndromes in the era of next-generation sequencing.
Kohlmann A; Bacher U; Schnittger S; Haferlach T
Leuk Lymphoma; 2014 Aug; 55(8):1725-34. PubMed ID: 24144312
[TBL] [Abstract][Full Text] [Related]
15. Precision Medicine in Myelodysplastic Syndromes and Leukemias: Lessons from Sequential Mutations.
Nazha A; Sekeres MA
Annu Rev Med; 2017 Jan; 68():127-137. PubMed ID: 27618752
[TBL] [Abstract][Full Text] [Related]
16. Mutational profiling in patients with MDS: ready for every-day use in the clinic?
Bacher U; Kohlmann A; Haferlach T
Best Pract Res Clin Haematol; 2015 Mar; 28(1):32-42. PubMed ID: 25659728
[TBL] [Abstract][Full Text] [Related]
17. Prognostic models in myelodysplastic syndromes.
Bejar R
Hematology Am Soc Hematol Educ Program; 2013; 2013():504-10. PubMed ID: 24319225
[TBL] [Abstract][Full Text] [Related]
18. Making sense of the myelodysplastic/myeloproliferative neoplasms overlap syndromes.
Tiu RV; Sekeres MA
Curr Opin Hematol; 2014 Mar; 21(2):131-40. PubMed ID: 24378705
[TBL] [Abstract][Full Text] [Related]
19. [Sequential acquisition of mutations in myelodysplastic syndromes].
Makishima H
Rinsho Ketsueki; 2017; 58(10):1828-1837. PubMed ID: 28978821
[TBL] [Abstract][Full Text] [Related]
20. Genetic and molecular characterization of myelodysplastic syndromes and related myeloid neoplasms.
Patel B; Hirsch C; Clemente M; Sekeres M; Makishima H; Maciejewski JP
Int J Hematol; 2015 Mar; 101(3):213-8. PubMed ID: 25690487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
